1916273_1916273

CGA PS-44 (R2022)

CGA Position Statement on Designated Medical Gases are Not Active Pharmaceutical Ingredients

Position Statement by Compressed Gas Association , 03/13/2016

View all product details

Most Recent

Track It

Language:
    • Available Formats
    • Options
    • Availability
    • Priced From ( in USD )
    • Secure PDF 🔒
    • 👥
    • Immediate download
    • $15.00
    • Add to Cart
    • Printed Edition
    • Ships in 1-2 business days
    • $15.00
    • Add to Cart
    • Printed Edition + PDF
    • Immediate download
    • $20.00
    • Add to Cart

Customers Who Bought This Also Bought

 

About This Item

 

Full Description

This position statement answers the questions: “Are designated medical gases ever considered active pharmaceutical ingredients (API) by the U.S. Food and Drug Administration (FDA)?” and “Are manufacturers of designated medical gases required to register their facilities as API manufacturers and list their products as APIs with the FDA for either human or animal drug use?”

 

Product Details

Edition:
1st
Published:
03/13/2016
Number of Pages:
2
File Size:
1 file , 130 KB
Note:
This product is unavailable in Russia, Ukraine, Belarus